10X GENOMICS, INC.

10X Genomics, Inc. specializes in the development and manufacturing of advanced genomic analysis systems and reagents for biomedical research and clinical diagnostics. Their core capabilities center on high-throughput single-cell and spatial genomics platforms, including the production of in vitro diagnostic substances, analytical laboratory instruments, and precision reagent kits for RNA sequencing and tissue profiling. The company delivers integrated solutions such as the Xenium Prime assay kits and Chromium Connect systems, enabling researchers to perform multiplexed molecular analysis with cellular resolution. Technical expertise includes microfluidics, barcoding technologies, and bioinformatics-enabled data pipelines, with a strong focus on reproducible, scalable workflows for translational science and precision medicine applications. Their ability to manufacture both instruments and consumables under unified quality systems represents a key differentiator in the life sciences market. The contractor maintains a dominant relationship with the Department of Health and Human Services, providing diagnostic reagents, assay kits, and instrument maintenance services critical to NIH and CDC research initiatives. Additional engagements with the Department of Veterans Affairs involve RNA sequencing library preparation for veteran health studies, while limited work with the Department of Defense and Department of Agriculture supports specialized biological research needs. Industry focus is concentrated in in-vitro diagnostic substance manufacturing and analytical laboratory instrument manufacturing, positioning 10X Genomics as a niche provider of next-generation sequencing infrastructure for government-funded biomedical labs. Their market presence is defined by end-to-end solutions spanning sample preparation, data generation, and assay validation. The company is headquartered in Pleasanton, California, and operates as a small business under the 2L entity structure. No federal certifications are listed, and their government market positioning is anchored in technical innovation rather than socio-economic designation.